Investing Profile

Mona Ashiya

InvestorVC
Partner at Orbimed
orbimed.comNew York, New York
Photo of Mona Ashiya, Partner at OrbiMed
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
4
$18B
CompanyStageDateRound SizeTotal Raised
Disc Medicine
Post Ipo EquityJun 2024$180M
Post Ipo EquityFeb 2023$64M
Post Ipo EquityAug 2022$54M
Post Ipo EquitySep 2021$90M
$440M
Co-investors: Kevin Bitterman (Atlas Venture), Mark Chin (Arix Bioscience)